2
Clinical Trials associated with Tengshen Granules / Not yet recruitingPhase 2IIT Multicenter, Double Blind, Randomized, Placebo-controlled Trial to Exploring the Role of Eye-Brain Multimodal Imaging in Diagnosing and Treating Neurovascular Coupling Impairment in Diabetes Mellitus
This study intends to take the critical pathological mechanism of diabetic neurovascular coupling injury (NCI) as the starting point and utilize multi-modal imaging (MMI) technology of the eyes and brain as a means to conduct in-depth, integrated, and interdisciplinary research with Traditional Chinese Medicine (TCM) syndrome studies. The aim is to establish diagnostic and therapeutic standards for diabetic NCI, based on Eye-Brain Multimodal Imaging technology, providing objective and quantitative evidence for early disease diagnosis and therapeutic effect evaluation. Simultaneously, investigators will conduct multicenter, randomized, placebo-controlled, double-blind clinical trials to systematically investigate the clinical efficacy and safety of Tangshen'an Granule in preventing and treating diabetic NCI. By obtaining high-quality evidence-based data on TCM, this study aims to enhance the level of prevention and treatment with TCM and clinical service capabilities, thereby providing new ideas and directions for research.
/ RecruitingNot Applicable A randomized, double-blind, placebo-controlled, single-center clinical trial of Tengshen granules in the treatment of grade 1 hypertension (severe liver heat and yang hyperactivity, mild kidney yin deficiency syndrome)
100 Clinical Results associated with Tengshen Granules
100 Translational Medicine associated with Tengshen Granules
100 Patents (Medical) associated with Tengshen Granules
100 Deals associated with Tengshen Granules